CalciMedica is trading 5.94% up at $2.14 after closing at $2.02 on September 8, 2026, with no clear company-specific catalyst identified.
- The only major announcement identified was CalciMedica’s September 15 participation in the H.C. Wainwright conference, which does not directly explain the move.
- Broader markets were mixed to weaker, providing limited macro support for the gain.